Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphoma

27 Jan 2020

Abstract excerpt

Currently, there are no clinically approved methods for predicting the relative efficacy of drug combinations for individual patients with cancer. Ex-vivo drug sensitivity experiments with patient-derived tumor material potentially offers a solution to identifying appropriate combinations of therapies for individual patients 1 . However, such assays are typically limited by the quantity available for...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CAR-T cell therapy research
Share to Chronic Lymphocytic Leukemia Research
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 31988286
DOI: 10.1038/s41408-020-0276-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Application of an ex-vivo drug sensitivity platform towards achieving complete remission in a refractory T-cell lymphomaPMID 31988286Read ↗

Optimizing drug combinations against multiple myeloma using a quadratic phenotypic optimization platform (QPOP).Semantic proximity Read ↗

Ex vivo drug testing in metastatic biopsies reveals patient-specific vulnerabilities to cancer targeting and immune activating drugsSemantic proximity Read ↗

A Combinatorial Functional Precision Medicine Platform for Rapid Therapeutic Response Prediction in AML.Semantic proximity Read ↗

Phenotypic response surface-guided pharmacotherapy for personalized combination treatment in complex diseases.Semantic proximity Read ↗

Phenotypic profiles for anticancer drug responses using tumor spheroids.Semantic proximity Read ↗

Phenotypic response surfaces in pharmacology: Mechanistic and translational perspectives on optimizing drug combination therapies.Semantic proximity Read ↗

A multidimensional impedance platform for the real-time analysis of single and combination drug pharmacology in patient-derived viable melanoma models.Semantic proximity Read ↗

Mechanism-independent optimization of combinatorial nanodiamond and unmodified drug delivery using a phenotypically driven platform technology.Semantic proximity Read ↗

Generation of a Predictive Melphalan Resistance Index by Drug Screen of B-Cell Cancer Cell LinesSemantic proximity Read ↗

A Quantitative Systems Pharmacology Model of T Cell Engager Applied to Solid TumorSemantic proximity Read ↗

Towards a platform quantitative systems pharmacology (QSP) model for preclinical to clinical translation of antibody drug conjugates (ADCs)Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.